BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 35107382)

  • 1. Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4
    Kim EH; Nguyen TQ; Casel MAB; Rollon R; Kim SM; Kim YI; Yu KM; Jang SG; Yang J; Poo H; Jung JU; Choi YK
    J Virol; 2022 Mar; 96(6):e0187321. PubMed ID: 35107382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets.
    Huang Y; Skarlupka AL; Jang H; Blas-Machado U; Holladay N; Hogan RJ; Ross TM
    J Virol; 2022 Mar; 96(5):e0179121. PubMed ID: 34936487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza.
    Bao L; Deng W; Qi F; Lv Q; Song Z; Liu J; Gao H; Wei Q; Yu P; Xu Y; Qu Y; Li F; Xue J; Gong S; Liu M; Wang G; Wang S; Zhao B; Cong B; Qin C
    Signal Transduct Target Ther; 2021 May; 6(1):200. PubMed ID: 34016949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.
    Oishi K; Horiuchi S; Minkoff JM; tenOever BR
    J Virol; 2022 Aug; 96(15):e0076522. PubMed ID: 35862681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters.
    Zhang AJ; Lee AC; Chan JF; Liu F; Li C; Chen Y; Chu H; Lau SY; Wang P; Chan CC; Poon VK; Yuan S; To KK; Chen H; Yuen KY
    Clin Infect Dis; 2021 Jun; 72(12):e978-e992. PubMed ID: 33216851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity.
    Achdout H; Vitner EB; Politi B; Melamed S; Yahalom-Ronen Y; Tamir H; Erez N; Avraham R; Weiss S; Cherry L; Bar-Haim E; Makdasi E; Gur D; Aftalion M; Chitlaru T; Vagima Y; Paran N; Israely T
    Nat Commun; 2021 Oct; 12(1):5819. PubMed ID: 34611155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity.
    Bai L; Zhao Y; Dong J; Liang S; Guo M; Liu X; Wang X; Huang Z; Sun X; Zhang Z; Dong L; Liu Q; Zheng Y; Niu D; Xiang M; Song K; Ye J; Zheng W; Tang Z; Tang M; Zhou Y; Shen C; Dai M; Zhou L; Chen Y; Yan H; Lan K; Xu K
    Cell Res; 2021 Apr; 31(4):395-403. PubMed ID: 33603116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone-Based Contraceptives Reduce Adaptive Immune Responses and Protection against Sequential Influenza A Virus Infections.
    Hall OJ; Nachbagauer R; Vermillion MS; Fink AL; Phuong V; Krammer F; Klein SL
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global dynamics of IAV/SARS-CoV-2 coinfection model with eclipse phase and antibody immunity.
    Elaiw AM; Alsulami RS; Hobiny AD
    Math Biosci Eng; 2023 Jan; 20(2):3873-3917. PubMed ID: 36899609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice.
    Li H; Zhao X; Zhao Y; Li J; Zheng H; Xue M; Guo L; Zhou J; Yang J; Zuo Y; Chen Y; Yang Z; Fan Q; Qin L; Shi H; Liu L
    Emerg Microbes Infect; 2021 Dec; 10(1):1156-1168. PubMed ID: 34060982
    [No Abstract]   [Full Text] [Related]  

  • 11. Animal Models of COVID-19: Transgenic Mouse Model.
    Park JG; Pino PA; Akhter A; Alvarez X; Torrelles JB; Martinez-Sobrido L
    Methods Mol Biol; 2022; 2452():259-289. PubMed ID: 35554912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques.
    Hasenkrug KJ; Feldmann F; Myers L; Santiago ML; Guo K; Barrett BS; Mickens KL; Carmody A; Okumura A; Rao D; Collins MM; Messer RJ; Lovaglio J; Shaia C; Rosenke R; van Doremalen N; Clancy C; Saturday G; Hanley P; Smith BJ; Meade-White K; Shupert WL; Hawman DW; Feldmann H
    mBio; 2021 Aug; 12(4):e0150321. PubMed ID: 34311582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-infection of SARS-CoV-2 and influenza virus causes more severe and prolonged pneumonia in hamsters.
    Kinoshita T; Watanabe K; Sakurai Y; Nishi K; Yoshikawa R; Yasuda J
    Sci Rep; 2021 Oct; 11(1):21259. PubMed ID: 34711897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor.
    Cao N; Cai Y; Huang X; Jiang H; Huang Z; Xing L; Lu L; Jiang S; Xu W
    mBio; 2024 May; 15(5):e0074124. PubMed ID: 38587427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.
    Golden JW; Zeng X; Cline CR; Garrison AR; White LE; Fitzpatrick CJ; Kwilas SA; Bowling PA; Fiallos JO; Moore JL; Sifford WB; Ricks KM; Mucker EM; Smith JM; Hooper JW
    J Gen Virol; 2021 May; 102(5):. PubMed ID: 33961540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coinfection With Influenza A Virus and
    Lee KM; Morris-Love J; Cabral DJ; Belenky P; Opal SM; Jamieson AM
    Front Immunol; 2018; 9():2377. PubMed ID: 30420852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-walled carbon nanotubes modulate pulmonary immune responses and increase pandemic influenza a virus titers in mice.
    Chen H; Zheng X; Nicholas J; Humes ST; Loeb JC; Robinson SE; Bisesi JH; Das D; Saleh NB; Castleman WL; Lednicky JA; Sabo-Attwood T
    Virol J; 2017 Dec; 14(1):242. PubMed ID: 29273069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion core.
    Shi R; Zeng J; Xu L; Wang F; Duan X; Wang Y; Wu Z; Yu D; Huang Q; Yao YG; Yan J
    EBioMedicine; 2022 Nov; 85():104297. PubMed ID: 36206623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Interactions during Viral-Viral Coinfection Can Shape Infection Kinetics.
    Pinky L; DeAguero JR; Remien CH; Smith AM
    Viruses; 2023 May; 15(6):. PubMed ID: 37376603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.